+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 175 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5893171
Description Jump to:
The global edema clinical trials market size is expected to reach USD 1.27 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030, according to the report. Several factors driving the growth of the market include the increasing prevalence of edema caused by underlying illnesses such as heart failure, kidney disorders, and liver cirrhosis, increasing expenditures on health care developments in medical research, among others.

In addition, edema research studies are anticipated to fuel the market’s expansion. For instance, in August 2021, Novartis announced encouraging findings from Phase III studies of Beovu treating diabetic macular edema, showing effective outcomes at up to 16-week intervals between doses. The KITE study's results from week 100 of the second year showed that most patients who finished the loading phases and the first 12-week cycle were kept on a 12 or 16-week dosing interval until the study's end.

Edema Clinical Trials Market Report Highlights

  • Based on phase, the phase-II segment accounted for the largest revenue share of 35.7% in 2022, as there is more extensive testing in a larger group of patients to assess both efficacy and safety in the phase-II segment. These trials aim to refine the dosage, identify adverse effects, and gather preliminary evidence of the treatment's effectiveness
  • The phase-III segment is expected to grow at a CAGR of 5.5% during the forecast period, as it is crucial for obtaining regulatory approval to provide strong evidence of a treatment's effectiveness and safety in a large, diverse patient population
  • Based on participant, the adult segment accounted for the largest revenue share of 48.9% in 2022 due to the possibility that they have a more extended history of the condition and a more diverse population regarding its origin and severity
  • Based on study design, the interventional trials segment accounted for the largest revenue share of 48.2% in 2022 and is expected to grow at the fastest CAGR of 5.8% over the forecast period. This design takes people from several countries and areas and frequently uses a multicenter technique
  • Based on type, the localized edema segment accounted for the largest revenue share of 63.5% in 2022. The frequency and intensity of localized edema in some populations would increase its significance in clinical trials for particular geographic areas or healthcare settings
  • In 2022, North America dominated the market with a revenue share of 41.4% as it consists of academic institutions, research facilities, and places for clinical trials. It also offers an advanced and robust research infrastructure. Asia Pacific is anticipated to grow at the fastest CAGR of 6.1% over the forecast period, with countries such as China and India serving as significant centers for pharmaceutical production and research


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Market Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Business Environment Analysis
3.4.1. PESTLE Analysis
3.4.2. Porter’s Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Phase Business Analysis
4.1. Edema Clinical Trials Market: Phase Movement Analysis, 2022 & 2030
4.2. Phase I
4.2.1. Phase I Market, 2018 - 2030 (USD Million)
4.3. Phase II
4.3.1. Phase II Market, 2018 - 2030 (USD Million)
4.4. Phase III
4.4.1. Phase III Market, 2018 - 2030 (USD Million)
4.5. Phase IV
4.5.1. Phase IV Market, 2018 - 2030 (USD Million)
Chapter 5. Participant Business Analysis
5.1. Edema Clinical Trials Market: Participant Movement Analysis, 2022 & 2030
5.2. Pediatrics
5.2.1. Pediatric Market, 2018 - 2030 (USD Million)
5.3. Adults
5.3.1. Adults Market, 2018 - 2030 (USD Million)
5.4. Geriatrics
5.4.1. Geriatrics Market, 2018 - 2030 (USD Million)
Chapter 6. Sponsor Business Analysis
6.1. Edema Clinical Trials Market: Sponsor Movement Analysis, 2022 & 2030
6.2. Pharmaceutical Companies
6.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
6.3. Academic Institutions
6.3.1. Academic Institutions Market, 2018 - 2030 (USD Million)
6.4. Government Bodies
6.4.1. Government Bodies Market, 2018 - 2030 (USD Million)
Chapter 7. Type Business Analysis
7.1. Edema Clinical Trials Market: Type Movement Analysis, 2022 & 2030
7.2. Systemic Edema
7.2.1. Systemic Edema Market, 2018 - 2030 (USD Million)
7.3. Localized Edema
7.3.1. Localized Edema Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Snapshot
8.2. North America
8.2.1. North America Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.2.2.2. Key Country Dynamics
8.2.2.3. Regulatory Framework
8.2.2.4. Competitive Scenario
8.2.3. Canada
8.2.3.1. Canada Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.2.3.2. Key Country Dynamics
8.2.3.3. Regulatory Framework
8.2.3.4. Competitive Scenario
8.3. Europe
8.3.1. Europe Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.2. Germany
8.3.2.1. Germany Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.2.2. Key Country Dynamics
8.3.2.3. Regulatory Framework
8.3.2.4. Competitive Scenario
8.3.3. UK
8.3.3.1. UK Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.3.2. Key Country Dynamics
8.3.3.3. Regulatory Framework
8.3.3.4. Competitive Scenario
8.3.4. France
8.3.4.1. France Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.4.2. Key Country Dynamics
8.3.4.3. Regulatory Framework
8.3.4.4. Competitive Scenario
8.3.5. Italy
8.3.5.1. Italy Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.5.2. Key Country Dynamics
8.3.5.3. Regulatory Framework
8.3.5.4. Competitive Scenario
8.3.6. Spain
8.3.6.1. Spain Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.6.2. Key Country Dynamics
8.3.6.3. Regulatory Framework
8.3.6.4. Competitive Scenario
8.3.7. Denmark
8.3.7.1. Denmark Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.7.2. Key Country Dynamics
8.3.7.3. Regulatory Framework
8.3.7.4. Competitive Scenario
8.3.8. Sweden
8.3.8.1. Sweden Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.8.2. Key Country Dynamics
8.3.8.3. Regulatory Framework
8.3.8.4. Competitive Scenario
8.3.9. Norway
8.3.9.1. Norway Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.9.2. Key Country Dynamics
8.3.9.3. Regulatory Framework
8.3.9.4. Competitive Scenario
8.4. Asia Pacific
8.4.1. Asia Pacific Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.2.2. Key Country Dynamics
8.4.2.3. Regulatory Framework
8.4.2.4. Competitive Scenario
8.4.3. China
8.4.3.1. China Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.3.2. Key Country Dynamics
8.4.3.3. Regulatory Framework
8.4.3.4. Competitive Scenario
8.4.4. India
8.4.4.1. India Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.4.2. Key Country Dynamics
8.4.4.3. Regulatory Framework
8.4.4.4. Competitive Scenario
8.4.5. South Korea
8.4.5.1. South Korea Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.5.2. Key Country Dynamics
8.4.5.3. Regulatory Framework
8.4.5.4. Competitive Scenario
8.4.6. Australia
8.4.6.1. Australia Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.6.2. Key Country Dynamics
8.4.6.3. Regulatory Framework
8.4.6.4. Competitive Scenario
8.4.7. Thailand
8.4.7.1. Thailand Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.7.2. Key Country Dynamics
8.4.7.3. Regulatory Framework
8.4.7.4. Competitive Scenario
8.5. Latin America
8.5.1. Latin America Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.5.2.2. Key Country Dynamics
8.5.2.3. Regulatory Framework
8.5.2.4. Competitive Scenario
8.5.3. Mexico
8.5.3.1. Mexico Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.5.3.2. Key Country Dynamics
8.5.3.3. Regulatory Framework
8.5.3.4. Competitive Scenario
8.5.4. Argentina
8.5.4.1. Argentina Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.5.4.2. Key Country Dynamics
8.5.4.3. Regulatory Framework
8.5.4.4. Competitive Scenario
8.6. MEA
8.6.1. MEA Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.6.2.2. Key Country Dynamics
8.6.2.3. Regulatory Framework
8.6.2.4. Competitive Scenario
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.6.3.2. Key Country Dynamics
8.6.3.3. Regulatory Framework
8.6.3.4. Competitive Scenario
8.6.4. UAE
8.6.4.1. UAE Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.6.4.2. Key Country Dynamics
8.6.4.3. Regulatory Framework
8.6.4.4. Competitive Scenario
8.6.5. Kuwait
8.6.5.1. Kuwait Edema Clinical Trials Market, 2018 - 2030 (USD Million)
8.6.5.2. Key Country Dynamics
8.6.5.3. Regulatory Framework
8.6.5.4. Competitive Scenario
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Acquisition
9.2.2. Collaborations
9.2.3. New Platform Launches
9.2.4. Others
9.3. Company Profiles/Listing
9.3.1. Otsuka Holdings
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Platform Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Hoffmann-La Roche
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Platform Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Novartis Pharmaceuticals
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Platform Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Bayer
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Platform Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Genentech, Inc
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Platform Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Biogen
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Platform Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Johnson & Johnson
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Platform Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Merck & Co., Inc.
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Platform Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Sanofi S.A.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Platform Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. AstraZeneca plc
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Platform Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Bristol Myers Squibb Company
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Platform Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. GlaxoSmithKline plc
9.3.12.1. Company Overview
9.3.12.2. Financial Performance
9.3.12.3. Platform Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. AbbVie Inc.
9.3.13.1. Company Overview
9.3.13.2. Financial Performance
9.3.13.3. Platform Benchmarking
9.3.13.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Global Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 4 Global Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 5 Global Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 6 Global Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 7 Global Edema Clinical Trial Market by Region, 2018 - 2030 (USD Million)
Table 8 North America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 9 North America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 10 North America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 11 North America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 12 North America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 13 U.S. Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 14 U.S. Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 15 U.S. Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 16 U.S. Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 17 Canada Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 18 Canada Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 19 Canada Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 20 Canada Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 21 Europe Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 22 Europe Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 23 Europe Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 24 Europe Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 25 Europe Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 26 Germany Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 27 Germany Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 28 Germany Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 29 Germany Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 30 UK Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 31 UK Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 32 UK Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 33 UK Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 34 France Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 35 France Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 36 France Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 37 France Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 38 Italy Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 39 Italy Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 40 Italy Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 41 Italy Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 42 Spain Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 43 Spain Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 44 Spain Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 45 Spain Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 46 Denmark Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 47 Denmark Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 48 Denmark Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 49 Denmark Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 50 Sweden Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 51 Sweden Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 52 Sweden Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 53 Sweden Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 54 Norway Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 55 Norway Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 56 Norway Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 57 Norway Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 63 China Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 64 China Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 65 China Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 66 China Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 67 Japan Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 68 Japan Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 69 Japan Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 70 Japan Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 71 India Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 72 India Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 73 India Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 74 India Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 75 South Korea Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 76 South Korea Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 77 South Korea Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 78 South Korea Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 79 Australia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 80 Australia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 81 Australia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 82 Australia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 83 Thailand Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 84 Thailand Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 85 Thailand Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 86 Thailand Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 87 Latin America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 88 Latin America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 89 Latin America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 90 Latin America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 91 Latin America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 92 Brazil Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 93 Brazil Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 94 Brazil Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 95 Brazil Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 96 Mexico Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 97 Mexico Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 98 Mexico Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 99 Mexico Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 100 Argentina Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 101 Argentina Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 102 Argentina Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 103 Argentina Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 109 South Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 110 South Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 111 South Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 112 South Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 117 UAE Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 118 UAE Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 119 UAE Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 120 UAE Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
Table 121 Kuwait Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
Table 122 Kuwait Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
Table 123 Kuwait Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
Table 124 Kuwait Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Edema Clinical Trial Market: Market Segmentation
Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 14 Regional Marketplace: Key Takeaways
Fig. 15 Global Edema Clinical Trial Market for Phase I, 2018 - 2030 (USD Million)
Fig. 16 Global Edema Clinical Trial Market for Phase II, 2018 - 2030 (USD Million)
Fig. 17 Global Edema Clinical Trial Market for Phase III, 2018 - 2030 (USD Million)
Fig. 18 Global Edema Clinical Trial Market for Phase IV, 2018 - 2030 (USD Million)
Fig. 19 Global Edema Clinical Trial Market for Pediatrics , 2018 - 2030 (USD Million)
Fig. 20 Global Edema Clinical Trial Market for Adults, 2018 - 2030 (USD Million)
Fig. 21 Global Edema Clinical Trial Market for Geriatrics, 2018 - 2030 (USD Million)
Fig. 22 Global Edema Clinical Trial Market for Pharmaceutical Companies, 2018 - 2030 (USD Million)
Fig. 23 Global Edema Clinical Trial Market for Academic Institutions, 2018 - 2030 (USD Million)
Fig. 24 Global Edema Clinical Trial Market for Government Bodies, 2018 - 2030 (USD Million)
Fig. 25 Global Edema Clinical Trial Market for Systemic Edema, 2018 - 2030 (USD Million)
Fig. 26 Global Edema Clinical Trial Market for Localized Edema, 2018 - 2030 (USD Million)
Fig. 27 Regional Outlook, 2022 & 2030
Fig. 28 North America Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 29 U.S. Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 30 Canada Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 31 Europe Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 32 Germany Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 33 UK Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 34 France Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 35 Italy Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 36 Spain Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 37 Denmark Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 38 Sweden Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 39 Norway Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 40 Asia Pacific Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 41 Japan Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 42 China Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 43 India Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 44 Australia Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 45 South Korea Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 46 Thailand Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 47 Latin America Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 48 Brazil Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 49 Mexico Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 50 Argentina Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 51 Middle East and Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 52 South Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 54 UAE Edema Clinical Trial Market 2018 - 2030 (USD Million)
Fig. 55 Kuwait Edema Clinical Trial Market 2018 - 2030 (USD Million)

Companies Profiled

  • Otsuka Holdings
  • Hoffmann-La Roche
  • Novartis Pharmaceuticals
  • Bayer
  • Genentech, Inc
  • Biogen
  • Johnson & Johnson
  • Merck & Co., Inc.
Sanofi S.A.
  • AstraZeneca plc
  • Bristol Myers Squibb Company
  • GlaxoSmithKline plc
  • AbbVie Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages175
PublishedNovember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 830 Million
Forecasted Market Value ( USD ) by 2030 $ 1270 Million
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Global Edema Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Image

Global Edema Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • 115 Pages
  • Global
From
Edema Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Edema Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 181 Pages
  • Global
From
Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease), By Phase, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease), By Phase, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 133 Pages
  • Global
From
India Ophthalmic Clinical Trials Market Size, Share & Trends Analysis Report By Product (Devices, Drugs/Pharmaceuticals), By Indication, By Phase, By Service Type, By Sponsor Type, And Segment Forecasts, 2023 - 2030 - Product Image

India Ophthalmic Clinical Trials Market Size, Share & Trends Analysis Report By Product (Devices, Drugs/Pharmaceuticals), By Indication, By Phase, By Service Type, By Sponsor Type, And Segment Forecasts, 2023 - 2030

  • Report
  • 90 Pages
  • India
From
Diabetic Macular Edema Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Image

Diabetic Macular Edema Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • 528 Pages
  • Global
From

About the Edema Drug Market

The Edema Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat edema, a condition characterized by swelling due to fluid accumulation in the body's tissues. These drugs are used to reduce swelling and improve symptoms such as pain, discomfort, and difficulty breathing. Commonly used edema drugs include diuretics, which reduce the amount of fluid in the body, and vasodilators, which relax the blood vessels and reduce swelling. Other drugs used to treat edema include ACE inhibitors, angiotensin receptor blockers, and calcium channel blockers. The Edema Drug market is highly competitive, with many companies offering a variety of drugs to treat edema. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.